Priming of CD8+ CTL effector cells in mice by immunization with a stress protein-influenza virus nucleoprotein fusion molecule

Vaccine

Volumn 17, Issue 4, 1999, Pages 373-383

  Anthony, Lawrence S D ^a   Wu, Huacheng ^a   Sweet, Heather ^a   Turnnir, Cor ^a   Boux, Leslie J ^a   Mizzen, Lee A ^a  

^a StressGen Biotechnologies Corp   (Canada)

Author keywords

Cytotoxic T lymphocyte; Heat shock protein; Influenza

Indexed keywords

HEAT SHOCK PROTEIN 65; HYBRID PROTEIN; RECOMBINANT PROTEIN; VIRUS NUCLEOPROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VIRUS; LYMPHOCYTE ACTIVATION; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEAT-SHOCK PROTEINS; IMMUNIZATION; IMMUNOPHENOTYPING; MICE; MICE, INBRED C57BL; NUCLEOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; VIRAL FUSION PROTEINS;

EID: 0345164329     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00199-6     Document Type: Article

References (51)

1. Barrios C., Lussow A.R., van Embden J., Van der Zee R., Rappuoli R., Constantino P., Louis J.A., Lambert P.-H., Del Giudice G. Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming. Eur J Immunol. 22:1992;1365-1372.
2. Barrios C., Georgopoulos C., Lambert P.-H., Del Giudice G. Mycobacterial heat-shock proteins as carrier molecules: in vivo helper effect mediated by Escherichia coli GroEL and DnaK proteins requires cross-linking with antigen. Clin Exp Immunol. 98:1994;229-233.
3. Lussow A.R., Barrios C., van Embden J., Van der Zee R., Verdini A.S., Pessi A., Louis J.A., Lambert P.-H., Del Giudice G. Mycobacterial heat-shock proteins as carrier molecules. Eur J Immunol. 21:1991;2297-2302.
4. Perraut R., Lussow A.R., Gavoille S., Garraud O., Matile H., Tougne C., van Embden J., Van der Zee R., Lambert P.-H., Gysin J., Del Giudice G. Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvants. Clin Exp Immunol. 93:1993;382-386.
5. Könen-Waisman S., Fridkin M., Cohen I.R. Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen. J Immunol. 154:1995;5977-5985.
6. Udono H., Srivastava P.K. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, Hsp90, and Hsp70. J Immunol. 152:1994;5398-5403.
7. Tamura Y., Peng P., Liu K., Daou M., Srivastava P.K. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science. 278:1997;117-120.
8. Udono H., Srivastava P.K. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med. 178:1993;1391-1396.
9. Georgopoulos C., Welch W.J. Role of the major heat shock proteins as molecular chaperones. Ann Rev Cell Biol. 9:1993;601-634.
10. Suto R., Srivastava P.K. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science. 269:1995;1585-1588.
11. Blachere N.E., Li Z., Chandawarkar R.Y., Suto R., Jaikaria N.S., Basu S., Udono H., Srivastava P.K. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med. 186:1997;1315-1322.
12. Ciupitu A.-M.T., Petersson .M, O'Donnell C.L., Williams K., Jindal S., Kiessling R., Welsh R.M. Immunization with lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J Exp Med. 187:1998;685-691.
13. Arnold D., Faath S., Rammensee H.-G., Schild H. Cross priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med. 182:1995;885-889.
14. Heikema A., Agsteribbe E., Wilschut J., Huckriede A. Generation of heat shock protein-based vaccines by intracellular loading of gp96 with antigenic peptides. Immunol Lett. 57:1997;69-74.
15. Suzue K., Young R. Adjuvant-free Hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J Immunol. 156:1996;873-879.
16. Suzue K., Young R. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Natl Acad Sci USA. 94:1997;13146-13151.
17. Young RA, Suzue K. Heat shock proteins as immunological carriers and vaccines. In: Feige U, Morimoto RI, Yahara I, Polla BS, editors. Stress-inducible cellular responses. Basel: Birkhauser-Verlag, 1996. pp. 451-465.
18. Townsend A.R.M., McMichael A.J., Carter N.P., Huddleston J.A., Brownlee G.G. Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell. 39:1984;13-25.
19. Van Eden W., Thole J.E., van der Zee R., Nordzij A., van Embden J.D., Hensen E.J., Cohen I.R. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature. 331:1988;171-173.
20. Botzler C., Issels R., Multhoff G. Heat-shock protein 72 cell-surface expression on human lung carcinoma cells is associated with an increased sensitivity to lysis mediated by adherent natural killer cells. Cancer Immunol Immunother. 43:1996;226-230.
21. Fisch P., Malkovsky M., Kovats S., Sturm E., Braakman E., Klein B.S., Voss S.D., Morrissey L.W., DeMars R., Welch W.J., Bolhuis R.L.H., Sondel P.M. Recognition by human Vγ9/Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science. 250:1990;1269-1273.
22. + T cells respond to mycobacterial heat-shock protein. Nature. 340:1989;309-312.
23. Kaur I., Voss S.D., Gupta R.S., Schell K., Fisch P., Sondel P.M. Human peripheral γδ T cells recognize Hsp60 molecules on Daudi Burkitt's lymphoma cells. J Immunol. 150:1993;2046-2055.
24. Multhoff G., Botzler C., Jennen L., Schmidt J., Ellwart J., Issels R. Heat shock protein 72 on tumor cells. A recognition structure for natural killer cells. J Immunol. 158:1997;4341-4350.
25. O'Brien R., Happ M.P., Dallas A., Palmer E., Kubo R., Born W.K. Stimulation of a major subset of lymphocytes expressing T cell receptor γδ by an antigen derived from Mycobacterium tuberculosis. Cell. 57:1989;667-674.
26. -, TCR-αβ-killer cells. J Immunol. 157:1996;3391-3395.
27. Tamura Y., Tsuboi N., Sato N., Kikuchi K. 70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host's anti-tumor immunity. J Immunol. 151:1993;5516-5524.
28. + T cells react to B cell lines expressing heat shock protein 70. J Immunol. 153:1994;4149-4158.
29. Fu Y.-X., Vollmer M., Kalataradi H., Heyborne K., Reardon C., Miles C., O'Brien R., Born W. Structural requirements for peptides that stimulate a subset of γδ T cells. J Immunol. 152:1994;1578-1588.
30. Warnier G., Dufour M.-T., Uyttenhove C., Gajewski T.F., Lurquin C., Haddada J., Perricaudet M., Boon T. Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A. Int J Cancer. 67:1996;303-310.
31. Fourie A.M., Sambrook J.F., Gething M.J.H. Common and divergent peptide binding specificities of hsp70 molecular chaperones. J Biol Chem. 269:1994;30470-30478.
32. Tamura S., Miyata K., Matsuo K., Asanuma H., Takahashi H., Nakajima K., Suzuki Y., Aizawa C., Kurata T. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J Immunol. 156:1996;3892-3900.
33. Tite J.P., Russell S.M., Dougan G., O'Callighan D., Jones I., Brownlee G., Liew F.Y. Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characteristics and cross-reactivity of T cell responses. J Immunol. 141:1988;3980-3987.
34. Tite J.P., Hughes-Jenkins C., O'Callighan D., Dougan G., Russell S.M., Gao X.-M., Liew F.Y. Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection. Immunology. 71:1990;202-207.
35. Wraith D.C., Vessey A.E., Askonas B.A. Purified influenza virus nucleoprotein protects mice from lethal infection. J Gen Virol. 68:1987;433-440.
36. + cytotoxic T lymphocyte responses. J Immunol. 148:1992;2357-2362.
37. Raychaudhuri S., Tonks M., Carbone F., Ryskamp T., Morrow W.J., Hanna N. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc Natl Acad Sci USA. 89:1992;8308-8312.
38. Schirmbeck R., Deml L., Melber K., Wolf H., Wagner R., Reimann J. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. Vaccine. 13:1995;857-865.
39. Beverly P.C.L. Generation of T cell memory. Curr Opin Immunol. 8:1996;327-330.
40. Lau L.L., Jamieson B.D., Somasundaram T., Ahmed R. Cytotoxic T cell memory without antigen. Nature. 369:1994;648-652.
41. Kündig T.M., Bachmann M.F., Oehen S., Hoffmann U.W., Simard J.J.L., Kalperer C.P., Pircher H., Ohashi P.S., Hengartner H., Zinkernagel R.M. On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci USA. 93:1996;9716-9723.
42. Williams D.B., Vassilakos A., Suh W.-K. Peptide presentation by MHC class I molecules. Trends Cell Biol. 6:1996;267-273.
43. b-restricted peptide presentation. Eur J Immunol. 27:1997;2016-2023.
44. Schutze-Radelmeier M.-P., Gournier H., Garcia-Pons F., Moussa M., Joliot A.H., Volovitch M., Prochiantz A., Lemmonier F.A. Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila Antennapedia homeodomain primes cytotoxic T cells in vivo. J Immunol. 157:1996;650-655.
45. Ballard J.D., Collier R.J., Starnbach M.N. Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc Natl Acad Sci USA. 93:1996;12531-12534.
46. Partidos C.D., Vohra P., Steward M.W. Priming of virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide. Virology. 215:1996;107-110.
47. Alder G.M., Austen B.M., Bashford C.L., Mehlert A., Pasternak C.A. Heat shock proteins induce pores in membranes. Biosci Reports. 10:1990;509-518.
48. Torok Z., Horvath I., Golubinoff P., Kovacs E., Glatz A., Balogh G., Vigh L. Evidence for a lipochaperonin: Association of active protein-folding GroESL oligomers with lipids can stabilize membranes under heat shock conditions. Proc Natl Acad Sci USA. 94:1997;2192-2197.
49. Soltys B.J., Gupta R.S. Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin (Hsp60) in mammalian cells. Exp Cell Res. 222:1996;16-27.
50. Ferrick D.A., Schrenzel M.D., Mulvania T., Hsieh B., Farlin W.G., Lepper H. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature. 373:1995;255-257.
51. + T cells. J Immunol. 156:1996;232-237.